Silverfin false false 31/01/2026 01/02/2025 31/01/2026 K Cox 25/06/2025 A Dubis 20/01/2026 E P Foster 20/04/2025 15/03/2024 M Picardo 28/07/2026 09/02/2024 A Robinson 01/10/2021 P West 17/04/2020 12 October 2026 no description of principal activity 12562594 2026-01-31 12562594 bus:Director1 2026-01-31 12562594 bus:Director2 2026-01-31 12562594 bus:Director3 2026-01-31 12562594 bus:Director4 2026-01-31 12562594 bus:Director5 2026-01-31 12562594 bus:Director6 2026-01-31 12562594 2025-01-31 12562594 core:CurrentFinancialInstruments 2026-01-31 12562594 core:CurrentFinancialInstruments 2025-01-31 12562594 core:ShareCapital 2026-01-31 12562594 core:ShareCapital 2025-01-31 12562594 core:SharePremium 2026-01-31 12562594 core:SharePremium 2025-01-31 12562594 core:RetainedEarningsAccumulatedLosses 2026-01-31 12562594 core:RetainedEarningsAccumulatedLosses 2025-01-31 12562594 core:PlantMachinery 2025-01-31 12562594 core:FurnitureFittings 2025-01-31 12562594 core:ComputerEquipment 2025-01-31 12562594 core:PlantMachinery 2026-01-31 12562594 core:FurnitureFittings 2026-01-31 12562594 core:ComputerEquipment 2026-01-31 12562594 bus:OrdinaryShareClass1 2026-01-31 12562594 2025-02-01 2026-01-31 12562594 bus:FilletedAccounts 2025-02-01 2026-01-31 12562594 bus:SmallEntities 2025-02-01 2026-01-31 12562594 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 12562594 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 12562594 bus:Director1 2025-02-01 2026-01-31 12562594 bus:Director2 2025-02-01 2026-01-31 12562594 bus:Director3 2025-02-01 2026-01-31 12562594 bus:Director4 2025-02-01 2026-01-31 12562594 bus:Director5 2025-02-01 2026-01-31 12562594 bus:Director6 2025-02-01 2026-01-31 12562594 core:PlantMachinery 2025-02-01 2026-01-31 12562594 core:FurnitureFittings 2025-02-01 2026-01-31 12562594 core:ComputerEquipment 2025-02-01 2026-01-31 12562594 2024-02-01 2025-01-31 12562594 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 12562594 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 12562594 (England and Wales)

VOX IMAGING TECHNOLOGY LTD

Unaudited Financial Statements
For the financial year ended 31 January 2026
Pages for filing with the registrar

VOX IMAGING TECHNOLOGY LTD

Unaudited Financial Statements

For the financial year ended 31 January 2026

Contents

VOX IMAGING TECHNOLOGY LTD

COMPANY INFORMATION

For the financial year ended 31 January 2026
VOX IMAGING TECHNOLOGY LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 January 2026
Directors K Cox (Appointed 25 June 2025)
A Dubis (Appointed 20 January 2026)
E P Foster (Resigned 20 April 2025)
M Picardo (Resigned 28 July 2026)
A Robinson
P West
Registered office International House
64 Nile Street
London
N1 7SR
United Kingdom
Company number 12562594 (England and Wales)
Accountant Kreston Reeves LLP
Suite 2
Orchard House
Orchard Street
Canterbury
Kent
CT2 8AR

ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF
THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF VOX IMAGING TECHNOLOGY LTD

For the financial year ended 31 January 2026

ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF
THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF VOX IMAGING TECHNOLOGY LTD (continued)

For the financial year ended 31 January 2026

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Vox Imaging Technology Ltd for the financial year ended 31 January 2026 which comprise the Balance Sheet and the related notes 1 to 9 from the Company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/regulation.

This report is made solely to the Board of Directors of Vox Imaging Technology Ltd, as a body, in accordance with the terms of our engagement letter dated 07 August 2024. Our work has been undertaken solely to prepare for your approval the financial statements of Vox Imaging Technology Ltd and state those matters that we have agreed to state to the Board of Directors of Vox Imaging Technology Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Vox Imaging Technology Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Vox Imaging Technology Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Vox Imaging Technology Ltd. You consider that Vox Imaging Technology Ltd is exempt from the statutory audit requirement for the financial year.

We have not been instructed to carry out an audit or a review of the financial statements of Vox Imaging Technology Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Kreston Reeves LLP

Suite 2
Orchard House
Orchard Street
Canterbury
Kent
CT2 8AR

13 October 2026

VOX IMAGING TECHNOLOGY LTD

BALANCE SHEET

As at 31 January 2026
VOX IMAGING TECHNOLOGY LTD

BALANCE SHEET (continued)

As at 31 January 2026
Note 2026 2025
£ £
Fixed assets
Tangible assets 3 8,123 7,889
8,123 7,889
Current assets
Debtors 4 32,102 ( 15,917)
Cash at bank and in hand 36,126 22,569
68,228 6,652
Creditors: amounts falling due within one year 5 ( 14,622) ( 25,302)
Net current assets/(liabilities) 53,606 (18,650)
Total assets less current liabilities 61,729 (10,761)
Net assets/(liabilities) 61,729 ( 10,761)
Capital and reserves
Called-up share capital 6 14 11
Share premium account 302,247 148,249
Profit and loss account 8 ( 240,532 ) ( 159,021 )
Total shareholders' funds/(deficit) 61,729 ( 10,761)

For the financial year ending 31 January 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Vox Imaging Technology Ltd (registered number: 12562594) were approved and authorised for issue by the Board of Directors on 12 October 2026. They were signed on its behalf by:

P West
Director
VOX IMAGING TECHNOLOGY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
VOX IMAGING TECHNOLOGY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 January 2026
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Vox Imaging Technology Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is International House, 64 Nile Street, London, N1 7SR, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Research and Development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery 25 % reducing balance
Fixtures and fittings 25 % reducing balance
Computer equipment 25 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

2. Employees

2026 2025
Number Number
Monthly average number of persons employed by the Company during the year, including directors 3 2

3. Tangible assets

Plant and machinery Fixtures and fittings Computer equipment Total
£ £ £ £
Cost
At 01 February 2025 2,301 1,018 8,358 11,677
Additions 107 1,189 1,447 2,743
At 31 January 2026 2,408 2,207 9,805 14,420
Accumulated depreciation
At 01 February 2025 549 210 3,029 3,788
Charge for the financial year 456 448 1,605 2,509
At 31 January 2026 1,005 658 4,634 6,297
Net book value
At 31 January 2026 1,403 1,549 5,171 8,123
At 31 January 2025 1,752 808 5,329 7,889

4. Debtors

2026 2025
£ £
Amounts owed by directors 79 ( 23,974)
Prepayments 1,236 2,637
VAT recoverable 1,237 4,779
Corporation tax 28,909 0
Other debtors 641 641
32,102 ( 15,917)

5. Creditors: amounts falling due within one year

2026 2025
£ £
Trade creditors 3,739 22,435
Accruals 7,605 2,310
Other taxation and social security 871 557
Other creditors 2,407 0
14,622 25,302

6. Called-up share capital

2026 2025
£ £
Allotted, called-up and fully-paid
1,354,157 Ordinary- paid shares of £ 0.00001 each (2025: 1,108,347 shares of £ 0.00001 each) 14 11

7. Financial commitments

Commitments

Total future minimum lease payments under non-cancellable operating leases are as follows:

2026 2025
£ £
Within one year 6,409 6,409

8. Reserves

Profit and loss account

This reserve comprises all current and prior period retained profits and losses after deducting any distributions made to the Company's shareholders.

Share premium account

This reserve records the amount above nominal value received for the shares issued by the company. Share premium may only be utilised to write-off any expenses incurred or commissions paid on the issue of those shares, or to pay up new shares to be allotted to members as fully paid bonus shares.

9. Ultimate controlling party

In the opinion of the directors there is no controlling party.